Background illustration for clinical trials search

Paid Clinical Trials Waterbury

Discover 1,141 paid clinical trials in Waterbury, Connecticut. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Kick-Nic! Youth Quit Vaping App

for
Nicotine Vaping
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 12 - 19

Code: NCT06662305

Phase2, Recruiting

Music for Pain and Dementia

for
Alzheimer Disease, Dementia, Mild Cognitive Impairment,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 50 - 70+

Code: NCT07602283

Recruiting

MDMA in Borderline Personality Disorder

for
Borderline Personality Disorder
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 18 - 60

Code: NCT06683014

Phase2, Recruiting

The Potential Therapeutic Effects of Psychedelic, N, N-dimethyltryptamine (DMT), on Alcohol Use Disorder (AUD)

for
Alcohol Use Disorder (AUD), Alcohol-Related Disorders,
Location: New Haven CT
Sponsor: Yale University

Sex: All

Age: 21 - 65

Code: NCT06070649

Phase1, Recruiting

Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer

for
Colonic Neoplasms, Neoplasms, Colon
Location: New Haven CT, New York NY, The Bronx NY, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT05855200

Phase3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

for
Gastrointestinal Neoplasms
Location: New Haven CT, New Hyde Park NY, New York NY, Boston MA,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18+

Code: NCT07218926

Phase3, Recruiting

A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors

for
Advance Solid Tumors
Location: New Have CT, Santa Monica CA
Sponsor: Kivu Bioscience Inc.

Sex: All

Age: 18+

Code: NCT07229313

Phase1, Recruiting

Study of Lunresertib Alone or in Combination With RP-3500 or Debio 0123 in Patients With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, New Hyde Park NY, New York NY,
Sponsor: Debiopharm International SA

Sex: All

Age: 12+

Code: NCT04855656

Phase1, Recruiting

A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions

for
Myelodysplastic Syndromes
Location: New Haven CT, Westbury NY, Columbia MD, Toronto, London,
Sponsor: Takeda

Sex: All

Age: 18+

Code: NCT06499285

Phase3, Recruiting

CATALINA-2: A Clinical Study of TORL-1-23 in Platinum-resistant Ovarian Cancer.

for
Epithelial Ovarian Cancer, Primary Peritoneal,
Location: New Haven CT, New Brunswick NJ, Boston MA,
Sponsor: TORL Biotherapeutics, LLC

Sex: Female

Age: 18+

Code: NCT06690775

Phase2, Recruiting

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

for
Acute Myeloid Leukemia, Mixed Lineage Leukemia Gene Mutation,
Location: New Haven CT, Stony Brook NY, New York NY,
Sponsor: Kura Oncology, Inc.

Sex: All

Age: 18+

Code: NCT05735184

Phase1, Recruiting

SNV1521 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Philadelphia PA, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06220864

Phase1, Recruiting

A Study of Sacituzumab Govitecan (IMMU-132) in Patients With Recurrent or Persistent Cervical Cancer

for
Cervical Cancer
Location: New Haven CT, Cleveland OH
Sponsor: Yale University

Sex: Female

Age: 18+

Code: NCT05838521

Phase2, Recruiting

Pembrolizumab and Brentuximab Vedotin in Subjects With Relapsed/Refractory T-cell Lymphoma

for
T-Cell Lymphoma
Location: New Haven CT, Boston MA
Sponsor: Yale University

Sex: All

Age: 18+

Code: NCT05313243

Phase2, Recruiting

Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

for
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC),
Location: New Haven CT, New York NY, Boston MA, Baltimore MD,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06040541

Phase1, Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: New Haven CT, Stony Brook NY, New York NY, Albany NY,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

for
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer,
Location: New Haven CT, The Bronx NY, Hackensack NJ, New York NY,
Sponsor: Revolution Medicines, Inc.

Sex: All

Age: 18+

Code: NCT06881784

Phase3, Recruiting

A Study to Evaluate the Efficacy and Safety of Sacituzumab Tirumotecan (MK-2870) Maintenance Treatment Versus Standard of Care in Participants With Platinum-sensitive Recurrent Ovarian Cancer (MK-2870-022/TroFuse-022/ENGOT-ov84/GOG-3103)

for
Ovarian Cancer, Fallopian Tube Cancer,
Location: New Haven CT, Mineola NY, Hackensack NJ, New York NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: Female

Age: 18+

Code: NCT06824467

Phase3, Recruiting

Heated Intraperitoneal Chemotherapy Followed by Niraparib for Ovarian, Primary Peritoneal and Fallopian Tube Cancer

for
Stage III Ovarian Cancer, Stage IV Ovarian Cancer,
Location: New Haven CT, Hartford CT, Teaneck NJ, New York NY,
Sponsor: GOG Foundation

Sex: Female

Age: 18+

Code: NCT05659381

Phase3, Recruiting

A First-in-human Study of PARP1 Selective Inhibitor, IMP1734, in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Providence RI, Toronto, Detroit MI,
Sponsor: Eikon Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06253130

Phase1, Phase2, Recruiting